PRL and cancer: Furthermore, excessive plasma prolactin levels have been associated with an increased risk of breast cancer in both premenopausal and postmenopausal women; is more prominent in estrogen or progestogen receptor cancer type (Tworoger et al., 2004; Tworoger et al., 2006).